These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 31062838)

  • 1. Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis.
    Coffeng LE; Stolk WA; Golden A; de Los Santos T; Domingo GJ; de Vlas SJ
    Am J Epidemiol; 2019 Sep; 188(9):1723-1732. PubMed ID: 31062838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus.
    Luz SL; Crainey JL; Shelley AJ; Rubio M
    Mem Inst Oswaldo Cruz; 2014 Jul; 109(4):506-8. PubMed ID: 25075790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Anti-OV-16 IgG4 Responses to Onchocerciasis after Elimination of Transmission in the Central Endemic Zone of Guatemala.
    Cama VA; Mendizabal-Cabrera R; de Leon O; White M; McDonald C; Thiele E; Ogawa GM; Morales Z; Prince-Guerra J; Cantey P; Rizzo N
    Am J Trop Med Hyg; 2024 May; 110(5):943-950. PubMed ID: 38507804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey.
    Hadermann A; Jada SR; Amaral LJ; Colebunders R; Bol YY; Siewe Fodjo JN
    Open Res Eur; 2023; 3():206. PubMed ID: 38617116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between Ov16 Rapid Diagnostic Test(RDT) and Ov16 Enzyme-Linked Immunosorbent Assay (ELISA) for the Diagnosis of Onchocerciasis in Areas of Contrasting Endemicity in Cameroon.
    Ekanya R; Beng AA; Anim MA; Pangwoh YZ; Dibando OE; Gandjui NVT; Awah AR; Amambo GN; Nchanji GT; Ndzeshang BL; Nji TM; Fombad FF; Njouendou AJ; Eyong EM; Cho JF; Eyong PA; Deribe K; Ngum NH; Golden A; Wanji S
    Parasite Epidemiol Control; 2023 May; 21():e00290. PubMed ID: 36875175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
    Cromwell EA; Osborne JCP; Unnasch TR; Basáñez MG; Gass KM; Barbre KA; Hill E; Johnson KB; Donkers KM; Shirude S; Schmidt CA; Adekanmbi V; Adetokunboh OO; Afarideh M; Ahmadpour E; Ahmed MB; Akalu TY; Al-Aly Z; Alanezi FM; Alanzi TM; Alipour V; Andrei CL; Ansari F; Ansha MG; Anvari D; Appiah SCY; Arabloo J; Arnold BF; Ausloos M; Ayanore MA; Baig AA; Banach M; Barac A; Bärnighausen TW; Bayati M; Bhattacharyya K; Bhutta ZA; Bibi S; Bijani A; Bohlouli S; Bohluli M; Brady OJ; Bragazzi NL; Butt ZA; Carvalho F; Chatterjee S; Chattu VK; Chattu SK; Cormier NM; Dahlawi SMA; Damiani G; Daoud F; Darwesh AM; Daryani A; Deribe K; Dharmaratne SD; Diaz D; Do HT; El Sayed Zaki M; El Tantawi M; Elemineh DA; Faraj A; Fasihi Harandi M; Fatahi Y; Feigin VL; Fernandes E; Foigt NA; Foroutan M; Franklin RC; Gubari MIM; Guido D; Guo Y; Haj-Mirzaian A; Hamagharib Abdullah K; Hamidi S; Herteliu C; Hidru HD; Higazi TB; Hossain N; Hosseinzadeh M; Househ M; Ilesanmi OS; Ilic MD; Ilic IM; Iqbal U; Irvani SSN; Jha RP; Joukar F; Jozwiak JJ; Kabir Z; Kalankesh LR; Kalhor R; Karami Matin B; Karimi SE; Kasaeian A; Kavetskyy T; Kayode GA; Kazemi Karyani A; Kelbore AG; Keramati M; Khalilov R; Khan EA; Khan MNN; Khatab K; Khater MM; Kianipour N; Kibret KT; Kim YJ; Kosen S; Krohn KJ; Kusuma D; La Vecchia C; Lansingh VC; Lee PH; LeGrand KE; Li S; Longbottom J; Magdy Abd El Razek H; Magdy Abd El Razek M; Maleki A; Mamun AA; Manafi A; Manafi N; Mansournia MA; Martins-Melo FR; Mazidi M; McAlinden C; Meharie BG; Mendoza W; Mengesha EW; Mengistu DT; Mereta ST; Mestrovic T; Miller TR; Miri M; Moghadaszadeh M; Mohammadian-Hafshejani A; Mohammadpourhodki R; Mohammed S; Mohammed S; Moradi M; Moradzadeh R; Moraga P; Mosser JF; Naderi M; Nagarajan AJ; Naik G; Negoi I; Nguyen CT; Nguyen HLT; Nguyen TH; Nikbakhsh R; Oancea B; Olagunju TO; Olagunju AT; Omar Bali A; Onwujekwe OE; Pana A; Pourjafar H; Rahim F; Rahman MHU; Rathi P; Rawaf S; Rawaf DL; Rawassizadeh R; Resnikoff S; Reta MA; Rezapour A; Rubagotti E; Rubino S; Sadeghi E; Saghafipour A; Sajadi SM; Samy AM; Sarmiento-Suárez R; Sawhney M; Schipp MF; Shaheen AA; Shaikh MA; Shamsizadeh M; Sharafi K; Sheikh A; Shetty BSK; Shin JI; Shivakumar KM; Simonetti B; Singh JA; Skiadaresi E; Soheili A; Soltani S; Spurlock EE; Sufiyan MB; Tabuchi T; Tapak L; Thompson RL; Thomson AJ; Traini E; Tran BX; Ullah I; Ullah S; Uneke CJ; Unnikrishnan B; Uthman OA; Vinkeles Melchers NVS; Violante FS; Wolde HF; Wonde TE; Yamada T; Yaya S; Yazdi-Feyzabadi V; Yip P; Yonemoto N; Yousof HSA; Yu C; Yu Y; Yusefzadeh H; Zaki L; Zaman SB; Zamanian M; Zhang ZJ; Zhang Y; Ziapour A; Hay SI; Pigott DM
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0008824. PubMed ID: 34319976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field sensitivity and specificity of the SD BIOLINE onchocerciasis IgG4 Rapid Diagnostic Test in children <10 years old from endemic areas in Burkina Faso.
    Nikièma AS; Koala L; Unnasch TR; Diendéré J; Compaoré J; Ouédraogo MW; Kafando CM; Bakajika D; Bougouma C; Faye B; Traoré S; Dabiré RK
    Parasite Epidemiol Control; 2024 May; 25():e00352. PubMed ID: 38708128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia Prevalence and
    Njamnshi WY; Siewe Fodjo JN; Njamnshi KG; Ngarka L; Mengnjo MK; Nfor LN; Tsasse MAF; Njamnshi JNT; Maestre G; Cavazos JE; Seshadri S; Etoundi Ngoa LS; Obama Abena Ondoa MT; Fongang B; Zoung-Kanyi Bissek AC; Njamnshi AK
    Pathogens; 2024 Jul; 13(7):. PubMed ID: 39057795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis.
    Coffeng LE; Graham M; Browning R; Kura K; Diggle PJ; Denwood M; Medley GF; Anderson RM; de Vlas SJ
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S153-S159. PubMed ID: 38662699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings.
    James A; Coffeng LE; Blok DJ; King JD; de Vlas SJ; Stolk WA
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S131-S137. PubMed ID: 38662696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs-monitoring of therapeutic drug efficacy as a case study.
    Coffeng LE; Vlaminck J; Cools P; Denwood M; Albonico M; Ame SM; Ayana M; Dana D; Cringoli G; de Vlas SJ; Fenwick A; French M; Kazienga A; Keiser J; Knopp S; Leta G; Matoso LF; Maurelli MP; Montresor A; Mirams G; Mekonnen Z; Corrêa-Oliveira R; Pinto SA; Rinaldi L; Sayasone S; Steinmann P; Thomas E; Vercruysse J; Levecke B
    PLoS Negl Trop Dis; 2023 May; 17(5):e0011071. PubMed ID: 37196017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa.
    Stolk WA; Coffeng LE; Bolay FK; Eneanya OA; Fischer PU; Hollingsworth TD; Koudou BG; Méité A; Michael E; Prada JM; Caja Rivera RM; Sharma S; Touloupou P; Weil GJ; de Vlas SJ
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010953. PubMed ID: 36508458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood transcriptome analysis in onchocerciasis.
    Lagatie O; Batsa Debrah L; Debrah AY; Stuyver LJ
    Curr Res Parasitol Vector Borne Dis; 2022; 2():100100. PubMed ID: 36082138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions.
    Biamonte MA; Cantey PT; Coulibaly YI; Gass KM; Hamill LC; Hanna C; Lammie PJ; Kamgno J; Nutman TB; Oguttu DW; Sankara DP; Stolk WA; Unnasch TR
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010682. PubMed ID: 35921329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
    Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
    Djune-Yemeli L; Domché A; Nana-Djeunga HC; Donfo-Azafack C; Lenou-Nanga CG; Masumbe-Netongo P; Kamgno J
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010380. PubMed ID: 35499993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage lot quality assurance sampling framework for monitoring and evaluation of neglected tropical diseases, allowing for imperfect diagnostics and spatial heterogeneity.
    Kazienga A; Coffeng LE; de Vlas SJ; Levecke B
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010353. PubMed ID: 35394996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening.
    Dusabimana A; Siewe Fodjo JN; Ndahura MM; Mmbando BP; Jada SR; Boven A; De Smet E; Ukety T; Njamnshi AK; Laudisoit A; Abrams S; Colebunders R
    Pathogens; 2022 Feb; 11(3):. PubMed ID: 35335605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the required performance and the development of corresponding program decision rules for neglected tropical diseases diagnostic tests: Monitoring and evaluation of soil-transmitted helminthiasis control programs as a case study.
    Levecke B; Coffeng LE; Hanna C; Pullan RL; Gass KM
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009740. PubMed ID: 34520474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
    Vinkeles Melchers NVS; Stolk WA; Murdoch ME; Pedrique B; Kloek M; Bakker R; de Vlas SJ; Coffeng LE
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009489. PubMed ID: 34115752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.